Antigenic peptides encoded by cancer germline genes used in the CSA
Protein . | HLA I restriction . | HLA frequency within the population, % . | Peptide sequence . |
|---|---|---|---|
| LAGE-1 | |||
| Alt-ORF | A2 | 44 | MLMAQEALAFL |
| NY-ESO | |||
| 157-165 | A2 | 44 | SLLMWITQC |
| MAGE-A1 | |||
| 96-104 | A3 | 23 | SLFRAVITK |
| 135-143 | A24 | 19 | NYKHCFPEI |
| 161-169 | A1 | 26 | EADPTGHSY |
| 289-298 | B7 | 17 | RVRFFFPSL |
| MAGE-A2 | |||
| 157-166 | A2 | 44 | YLQLVFGIEV |
| MAGE-A3 | |||
| 97-105 | A24 | 19 | TFPDLESEF |
| 112-120 | A2 | 44 | KVAEELVHFL |
| 168-176 | A1 | 26 | EVDPIGHLY |
| 195-203 | A24 | 19 | IMPKAGLLI |
| MAGE-A4 | |||
| 230-239 | A2 | 44 | GVYDGREHTV |
Protein . | HLA I restriction . | HLA frequency within the population, % . | Peptide sequence . |
|---|---|---|---|
| LAGE-1 | |||
| Alt-ORF | A2 | 44 | MLMAQEALAFL |
| NY-ESO | |||
| 157-165 | A2 | 44 | SLLMWITQC |
| MAGE-A1 | |||
| 96-104 | A3 | 23 | SLFRAVITK |
| 135-143 | A24 | 19 | NYKHCFPEI |
| 161-169 | A1 | 26 | EADPTGHSY |
| 289-298 | B7 | 17 | RVRFFFPSL |
| MAGE-A2 | |||
| 157-166 | A2 | 44 | YLQLVFGIEV |
| MAGE-A3 | |||
| 97-105 | A24 | 19 | TFPDLESEF |
| 112-120 | A2 | 44 | KVAEELVHFL |
| 168-176 | A1 | 26 | EVDPIGHLY |
| 195-203 | A24 | 19 | IMPKAGLLI |
| MAGE-A4 | |||
| 230-239 | A2 | 44 | GVYDGREHTV |